Blueprint Investment Partners LLC Edwards Lifesciences Corp Transaction History

Blueprint Investment Partners LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 15, 2023	BUY	$81.41 - $94.33 $204,501 - $236,956	2,512 New	2,512 $236,000
Q2 2022 Aug 09, 2022	SELL	$86.5 - $128.27 $222,824 - $330,423	-2,576 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$101.96 - $128.34 $262,648 - $330,603	2,576 New	2,576 $303,000
Q4 2021 Feb 15, 2022	SELL	$106.37 - $130.68 $199,869 - $245,547	-1,879 Closed	0 $0
Q3 2021 Nov 04, 2021	BUY	$102.91 - $122.75 $193,367 - $230,647	1,879 New	1,879 $213,000

1,351

455M

9.76M

3.92M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $41.9B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Blueprint Investment Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Blueprint Investment Partners LLC with notifications on news.